{{Drugbox
| verifiedrevid =
| IUPAC_name = 1-(4-Methoxyphenyl)-2-(pyrrolidin-1-yl)pentan-1-one
| image = MOPVP.svg
| width = 220

<!--Clinical data-->
| tradename =
| legal_UK = Class B
| legal_status = Illegal in China

<!--Identifiers-->
| CAS_number_Ref =
| CAS_number = 5537-19-9
| DrugBank_Ref =
| PubChem = 11299968
| ChemSpiderID_Ref =
| ChemSpiderID = 9474945
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = UM9572UF9L
| ChEMBL = 381127

<!--Chemical data-->
| C=16 | H=23 | N=1 | O=2
| molecular_weight = 261.17 g/mol
| smiles = COC1=CC=C(C(C(CCC)N2CCCC2)=O)C=C1.Cl
| StdInChI = 1S/C16H23NO2/c1-3-6-15(17-11-4-5-12-17)16(18)13-7-9-14(19-2)10-8-13/h7-10,15H,3-6,11-12H2,1-2H3
| StdInChIKey = HWYVHRCKBXGZLV-UHFFFAOYSA-N
}}

'''4'-Methoxy-α-pyrrolidinopentiophenone''' (also known as '''4-MeO-α-PVP''' and '''MOPVP''') is a [[stimulant]] [[drug]] of the [[substituted cathinone|cathinone]] [[chemical class|class]] that has been sold online as a [[designer drug]].<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/14097 | title=4-methoxy-α-Pyrrolidinopentiophenone | publisher=Cayman Chemical | accessdate=5 August 2015}}</ref><ref>{{cite web | url=https://google.com/patents/US20080234498A1 | title=Patent US 20080234498 A1 - Pyrovalerone Analogues and Therapeutic Uses Thereof | date=25 September 2008 | accessdate=6 August 2015 | author=David Butler | author2=Bertha K. Madras | author3=Peter C. Meltzer}}</ref><ref>{{cite journal | url=https://link.springer.com/article/10.1007%2Fs11419-013-0194-5 | title=Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A-834735, cathinone derivative 4-methoxy-α-PVP, and phenethylamine derivative 4-methylbuphedrine from illegal products | author=Nahoko Uchiyama | author2=Satoru Matsuda | author3=Maiko Kawamura| author4=Ruri Kikura-Hanajiri | author5=Yukihiro Goda | journal=Forensic Toxicology |date=January 2014  | volume=32 | issue=1 | pages=9–18 | doi=10.1007/s11419-013-0194-5}}</ref><ref>{{cite journal | url=https://link.springer.com/article/10.1007/s11419-015-0287-4 | title=4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry | author=Kayla N. Ellefsen | author2=Ariane Wohlfarth | author3=Madeleine J. Swortwood| author4=Xingxing Diao | author5=Marta Concheiro| author6=Marilyn A. Huestis | journal=Forensic Toxicology | date=August 2015| doi=10.1007/s11419-015-0287-4}}</ref>

==Legal Status==

As of October 2015 4-MeO-α-PVP is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>

== See also ==
* [[alpha-Pyrrolidinopentiophenone]]
* [[4'-Methoxy-α-pyrrolidinopropiophenone]]

== References ==
{{reflist}}

{{Stimulants}}
{{Phenethylamines}}

{{DEFAULTSORT:Methoxy-alpha-pyrrolidinopentiophenone, 4'-}}

[[Category:Designer drugs]]
[[Category:Norepinephrine-dopamine reuptake inhibitors]]
[[Category:Pyrrolidinophenones]]

{{nervous-system-drug-stub}}